Sahm Adrangi’s Kerrisdale knifes Proteostasis’ 'breakthrough' cystic fibrosis data in a brutal biotech short attack
Sahm Adrangi and his SWAT team at Kerrisdale Capital have put another biotech in their cross hairs.
The high-profile biotech investor — who’s taken on a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
